0R2M Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Regeneron Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 965.03 USD 5.02%

Market Cap: $101.4B

	Regeneron Pharmaceuticals Inc LSE:0R2M	US
N	Nokia Oyj SWB:NOA3	FI
	CCC Intelligent Solutions Holdings Inc NASDAQ:CCC	US
F	Fathom Nickel Inc CNSX:FNI	CA
I	Indocement Tunggal Prakarsa Tbk PT SWB:ITP	ID
	CCC Intelligent Solutions Holdings Inc F:0B1	US
K	Kanglim Co Ltd KOSDAQ:014200	KR
J	J B Hunt Transport Services Inc LSE:0J71	US
P	Philippos Nakas SA ATHEX:NAKAS	GR
G	Great Portland Estates PLC SWB:G9KB	UK
	Smith & Nephew PLC F:NPW1	UK
	Babcock International Group PLC LSE:BAB	UK
	Tex-Ray Industrial Co Ltd TWSE:1467	TW
I	Idico Corporation JSC VN:IDC	VN
	Ashika Credit Capital Ltd BSE:543766	IN

Profitability Summary

Regeneron Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

86%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

87% > 86%

Healthy Operating Margin

28%

Sustainable 3Y Average Operating Margin

29%

Declining Operating Margin

35% > 28%

Healthy Net Margin

28%

Strong 3Y Average Net Margin

31%

Declining Net Margin

30% > 28%

Exceptional Free Cash Flow Margin

23%

Strong 3Y Average Free Cash Flow Margin

25%

Declining Free Cash Flow Margin

33% > 23%

Positive ROE

14%

Positive 3Y Average ROE

Positive 3Y Average ROIC

15%

Declining ROIC

20% > 12%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.